The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-utility analysis of panitumumab use compared with cetuximab and bevacizumab for the first-line therapy of wild-typeRAS metastatic colorectal cancer in the Peruvian health system.
 
Valderrama Milton
No Relationships to Disclose
 
Moises Apolaya-Segura
No Relationships to Disclose
 
Paola Catherine Montenegro
No Relationships to Disclose